Information:
Fel:
ID
34150
Beskrivning
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00919880
Länk
https://clinicaltrials.gov/show/NCT00919880
Nyckelord
Versioner (1)
- 2019-01-14 2019-01-14 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
14 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00919880
Eligibility Breast Cancer NCT00919880
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00919880
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
female patients between 18 and 65 years old
boolean
ID.2
Item
pathological diagnosed invasive breast cancer; medium and high risk primary breast cancer according to st. gallen 2007
boolean
ID.3
Item
able and willing to give consent to participate in the study
boolean
ID.4
Item
pregnant or lactating females
boolean
ID.5
Item
previous treatment for breast cancer
boolean
ID.6
Item
other tumor history
boolean
ID.7
Item
instable complication (e.g., myocardial infarction within 6 months, arrhythmia, unstable diabetes, hypercalcemia) or uncontrolled infection
boolean
ID.8
Item
allergy history to similar drugs
boolean
ID.9
Item
concurrent disease or condition that would make the patient inappropriate for study participation
boolean
ID.10
Item
resist to participate in the study
boolean